巨子生物(02367)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02367 巨子生物

未开盘 05-06 16:08:33

80.800

+0.300

+0.37%

最高83.350	最低79.650	成交量431.62万
今开80.500	昨收80.500	日振幅4.60%
总市值865.37亿	流通市值865.37亿	总股本10.71亿
成交额3.49亿	换手率0.40%	流通股本10.71亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02367","market":"HK","secType":"STK","nameCN":"巨子生物","latestPrice":80.8,"timestamp":1746518913017,"preClose":80.5,"halted":0,"volume":4316200,"delay":0,"floatShares":1071000000,"shares":1071000000,"eps":2.2585528776248984,"marketStatus":"未开盘","change":0.3,"latestTime":"05-06 16:08:33","open":80.5,"high":83.35,"low":79.65,"amount":349007737,"amplitude":0.045963,"askPrice":80.8,"askSize":5600,"bidPrice":80.65,"bidSize":600,"shortable":3,"etf":0,"ttmEps":2.2151636082167356,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746581400000},"marketStatusCode":0,"adr":0,"listingDate":1667491200000,"exchange":"SEHK","adjPreClose":80.5,"dividendRate":0.012005,"openAndCloseTimeList":[[1746495000000,1746504000000],[1746507600000,1746518400000]],"volumeRatio":0.8350361205889602,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02367/tweets","defaultTab":"tweets","newsList":[{"id":"2533524393","title":"中金：五一消费恢复环比提速 看好居民消费需求持续释放","url":"https://stock-news.laohu8.com/highlight/detail?id=2533524393","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533524393?lang=zh_cn&edition=full","pubTime":"2025-05-06 14:45","pubTimestamp":1746513900,"startTime":"0","endTime":"0","summary":"展望后续，继续看好消费提振政策逐步显效，全年居民消费需求持续释放。此外，美团数据显示“五一”期间全国5000人以上大型演出超百场，观众人数超200万人次，上海、成都等地通过“票根经济”等模式延长消费链条，提升消费黏性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-05-06/doc-inevrepa7455954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0588546209.SGD","LU0348766576.USD","IE00BYV24P56.USD","BK0070","09992","BK0229","09896","603816","002831","BK1246","00325","LU2488822045.USD","BK0012","IE00BZ08YR35.GBP","BK0260","BK0196","603193","300662","BK0197","BK0185","BK1249","IE00BZ08YS42.EUR","300888","01318","BK0183","BK1224","IE00BMCWC346.EUR","BK0170","BK0209","LU0823426308.USD","002572","IE00BVYPNQ40.USD","IE00BVYPNP33.GBP","IE00BZ08YT58.USD","600315","LU0307460666.USD","BK0210","BK0247","LU2543165471.USD","BK0111","603833","LU0348767384.USD","603983","BK0222","605009","LU0823426480.USD","BK1213","601933","02367","SG9999004311.SGD"],"gpt_icon":1},{"id":"2531085451","title":"巨子生物04月30日主力净流出331.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2531085451","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531085451?lang=zh_cn&edition=full","pubTime":"2025-04-30 16:15","pubTimestamp":1746000940,"startTime":"0","endTime":"0","summary":"04月30日, 巨子生物股价跌0.25%，报收80.00元，成交金额4.9亿元，换手率0.57%，振幅3.68%，量比0.90。巨子生物今日主力资金净流出331.0万元，上一交易日主力净流入217.4万元。该股近5个交易日上涨6.94%，主力资金累计净流出688.6万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出5817.1万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430171034a6ce9af8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430171034a6ce9af8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999004311.SGD","LU2488822045.USD","02367","BK1207"],"gpt_icon":0},{"id":"2531046248","title":"财报面面观｜旧胄溃退，新贵登场：美妆行业内卷重构","url":"https://stock-news.laohu8.com/highlight/detail?id=2531046248","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531046248?lang=zh_cn&edition=full","pubTime":"2025-04-29 11:17","pubTimestamp":1745896629,"startTime":"0","endTime":"0","summary":"中国基金报记者赵心怡“潮水退去，才知道谁在裸泳。”这句话尽管被视为“陈词滥调”，但用来描述2024年美妆类上市公司的业绩表现却恰如其分。国家统计局数据显示，2024年中国社会消费品零售总额增长3.5%，但化妆品类商品零售额为4356.5亿元，同比下降1.1%。整体下滑的大环境中，不少外资品牌降价、撤柜，收缩战线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504293392585753.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504293392585753.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1207","LU2488822045.USD","02367","SG9999004311.SGD"],"gpt_icon":0},{"id":"2530288351","title":"巨子生物(02367)4月28日发行3500万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2530288351","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530288351?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:05","pubTimestamp":1745845500,"startTime":"0","endTime":"0","summary":"智通财经APP讯，巨子生物(02367)发布公告，按照日期为2025年4月16日的配售及认购协议，于2025年4月28日根据一般授权发行3500万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286723.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02367","SG9999004311.SGD","LU2488822045.USD","BK1207"],"gpt_icon":0},{"id":"2530886092","title":"巨子生物完成配售合共3500万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2530886092","media":"格隆汇资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530886092?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:03","pubTimestamp":1745845430,"startTime":"0","endTime":"0","summary":"格隆汇4月28日丨巨子生物(02367.HK)公告，公司欣然宣布，卖方配售已于2025年4月23日完成，而认购则已于2025年4月28日完成。补足卖方所持有的合共3500万股股份已按每股66.65港元的配售价成功配售予不少于六名专业、机构及╱或个人投资者，据董事作出一切合理查询后所深知、尽悉及确信，该等投资者连同彼等各自最终实益拥有人均为独立于本公司或其关连人士且与彼等概无关连的第三方。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821040894e5e99e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821040894e5e99e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999004311.SGD","BK1207","LU2488822045.USD","02367"],"gpt_icon":0},{"id":"2530516285","title":"每日卖空追踪 | 巨子生物 04月28日卖空量成交70.48万股，卖空比例为10.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530516285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530516285?lang=zh_cn&edition=full","pubTime":"2025-04-28 20:37","pubTimestamp":1745843826,"startTime":"0","endTime":"0","summary":"巨子生物北京时间04月28日，涨2.4%，卖空量成交70.48万股，较上一交易日增加139.08%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428211346a6cbba96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428211346a6cbba96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","SG9999004311.SGD","BK1207","02367"],"gpt_icon":0},{"id":"2530452784","title":"巨子生物：盘中涨近 3% 储备 9 种胶原","url":"https://stock-news.laohu8.com/highlight/detail?id=2530452784","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530452784?lang=zh_cn&edition=full","pubTime":"2025-04-28 11:36","pubTimestamp":1745811405,"startTime":"0","endTime":"0","summary":"据国家知识产权局中的专利信息，当前市场中大部分的重点公司已开发多种型别的重组胶原蛋白，不完全统计锦波生物和巨子生物均已储备 9 种型别的重组胶原蛋白类型。2025 年 1 月，巨子生物独家专利重组人Ⅳ型胶原蛋白获得国家知识产权局正式授权，并在 2 月上新以重组 IV 型胶原蛋白为核心成分的帧域密修系列产品；2024 年 8 月，公司重组人 XVII 型胶原蛋白，其制备方法及应用获得国家知识产权局正式授权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042814371997481125&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042814371997481125&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999004311.SGD","BK1207","02367","LU2488822045.USD"],"gpt_icon":0},{"id":"2530738411","title":"港股异动 | 巨子生物(02367)涨近3% 机构指中国重组胶原蛋白全球化提速 建议关注行业龙头布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2530738411","media":"智通财经网","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530738411?lang=zh_cn&edition=full","pubTime":"2025-04-28 10:18","pubTimestamp":1745806680,"startTime":"0","endTime":"0","summary":"2025年1月，巨子生物独家专利重组人Ⅳ型胶原蛋白获得国家知识产权局正式授权，并在2月上新以重组IV型胶原蛋白为核心成分的帧域密修系列产品；2024年8月，公司重组人XVII型胶原蛋白，其制备方法及应用获得国家知识产权局正式授权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-28/doc-ineustca2164108.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02367","SG9999004311.SGD","BK1207","LU2488822045.USD"],"gpt_icon":0},{"id":"2530549899","title":"中信证券：中国重组胶原蛋白全球化提速 “原料、妆、械”全面出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2530549899","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530549899?lang=zh_cn&edition=full","pubTime":"2025-04-28 08:33","pubTimestamp":1745800419,"startTime":"0","endTime":"0","summary":"最后，中国重组胶原蛋白全球化提速，“原料、妆、械”全面出海。据国家知识产权局中的专利信息，当前市场中大部分的重点公司已开发多种型别的重组胶原蛋白，不完全统计锦波生物和巨子生物均已储备9种型别的重组胶原蛋白类型。领先、创新、高品质，中国重组胶原出海前景广阔。原料方面，中国重组胶原蛋白原料可靠性与有效性持续获得国内外认可。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286059.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0405327148.USD","BK0196","LU2488822045.USD","BK0188","LU2495084118.USD","LU2289578879.USD","LU1064130708.USD","LU1655091616.SGD","02367","LU1064131003.USD","BK0028","BK1564","LU1997244956.HKD","LU1997245094.SGD","LU1720050803.USD","BK1147","LU0405327494.USD","06030","BK0276","BK0183","BK1207","SG9999004311.SGD","BK1516","BK0012","600030","LU2148510915.USD","LU1328615791.USD","LU1794554557.SGD","BK1521","LU1997245177.USD"],"gpt_icon":0},{"id":"2529692732","title":"巨子生物(02367)股东将股票由高盛(亚洲)证券转入花旗银行 转仓市值26.07亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529692732","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529692732?lang=zh_cn&edition=full","pubTime":"2025-04-24 08:22","pubTimestamp":1745454120,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，4月23日，巨子生物(02367)股东将股票由高盛(亚洲)证券转入花旗银行，转仓市值26.07亿港元，占比3.28%。巨子生物4月17日早上公布，配售最多3,500万股股份，相当于扩大后股本3.27%;配售价66.65港元，较上交易日(16日)收市价折让9.5%。集资总额23.33亿港元，所得净额22.94亿港元，配售及认购所得款项净额拟用于核心业务的发展及生态圈布局，包括品牌推广、市场营销、品类扩展、海外业务及研发投入;以及补充流动资金及作一般企业用途。巨子生物表示，集资主要用于海外业务发展，因其现金大部分在中国境内。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-24/doc-ineufnmc3683602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2462157665.USD","LU2750360641.GBP","LU1668664300.SGD","LU2456880835.USD","IE0004086264.USD","BK4207","LU2471134879.HKD","LU1868837300.USD","LU0128525689.USD","LU2750360997.AUD","IE00BSNM7G36.USD","SG9999004311.SGD","BK4566","LU2417539215.USD","161027","LU0162691827.USD","LU1162221912.USD","LU0106831901.USD","LU0130517989.USD","LU1868836591.USD","LU1868836757.USD","BK4550","BK4534","LU2237443382.USD","LU0061475181.USD","LU0251131958.USD","BK4516","LU2237443622.USD","IE0002270589.USD","LU2471134952.CNY","BK4585","LU0310800965.SGD","LU2488822045.USD","LU0742534661.SGD","LU2125154935.USD","IE0004091025.USD","LU2360032135.SGD","LU2237443895.HKD","LU2237438978.USD","IE00BFXG1179.USD","LU2237443978.SGD","IE0034235188.USD","IE00B19Z3B42.SGD","LU0980610538.SGD","02367","BK4588","BK4504","BK1207","LU2471134523.USD"],"gpt_icon":0},{"id":"2529316728","title":"巨子生物盘中涨超5% 陕西省药监局通报多批次可复美产品均未检出EGF","url":"https://stock-news.laohu8.com/highlight/detail?id=2529316728","media":"新浪网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529316728?lang=zh_cn&edition=full","pubTime":"2025-04-22 11:48","pubTimestamp":1745293698,"startTime":"0","endTime":"0","summary":"巨子生物盘中涨超5%，截至发稿，股价上涨4.16%，现报75.10港元，成交额4.38亿港元。国货美妆头部品牌可复美近日深陷“EGF添加门”舆论漩涡。陕西省药监局针对近日媒体对可复美品牌“检出违禁添加表皮生长因子EGF”的报道做出通报，多批次可复美产品均未检出EGF。据悉，可复美为巨子生物的核心品牌，2024年销售收入达45.42亿元，同比增长62.9%，占公司总营收的82%。尽管如此，巨子生物的盈利前景依然稳健。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042212232894dd9fea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042212232894dd9fea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","SG9999004311.SGD","LU2488822045.USD","BK1207"],"gpt_icon":0},{"id":"2529039394","title":"港股异动 | 巨子生物(02367)早盘涨超5% 陕西省药监局通报多批次可复美产品均未检出EGF","url":"https://stock-news.laohu8.com/highlight/detail?id=2529039394","media":"智通财经网","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529039394?lang=zh_cn&edition=full","pubTime":"2025-04-22 11:29","pubTimestamp":1745292540,"startTime":"0","endTime":"0","summary":"巨子生物早盘涨超5%，截至发稿，涨4.44%，报75.3港元，成交额4.22亿港元。消息面上，国货美妆头部品牌可复美近日深陷“EGF添加门”舆论漩涡。陕西省药监局针对近日媒体对可复美品牌“检出违禁添加表皮生长因子EGF”的报道做出通报，多批次可复美产品均未检出EGF。据悉，可复美为巨子生物的核心品牌，2024年销售收入达45.42亿元，同比增长62.9%，占公司总营收的82%。尽管如此，巨子生物的盈利前景依然稳健。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-22/doc-inetzeny4301594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2488822045.USD","SG9999004311.SGD","02367","BK1207","EGF"],"gpt_icon":0},{"id":"2529999493","title":"巨子生物盘中异动 早盘股价大涨5.06%报75.750港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529999493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529999493?lang=zh_cn&edition=full","pubTime":"2025-04-22 11:06","pubTimestamp":1745291164,"startTime":"0","endTime":"0","summary":"2025年04月22日早盘11时06分，巨子生物股票出现异动，股价急速拉升5.06%。截至发稿，该股报75.750港元/股，成交量462万股，换手率0.45%，振幅4.51%。资金方面，该股资金流入1.70393亿港元，流出1.09441亿港元。巨子生物股票所在的生物技术行业中，整体涨幅为3.64%。上市不到3年，巨子生物已公告两次配售，融资总金额近40亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422110605a461dd8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422110605a461dd8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","BK1207","LU2488822045.USD","SG9999004311.SGD"],"gpt_icon":0},{"id":"2529557843","title":"不差钱的巨子生物连续高位融资，主力产品遭投诉","url":"https://stock-news.laohu8.com/highlight/detail?id=2529557843","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529557843?lang=zh_cn&edition=full","pubTime":"2025-04-21 12:08","pubTimestamp":1745208515,"startTime":"0","endTime":"0","summary":"近日，巨子生物（02367）推出再融资计划后，股价应声下跌。4月17日早间，巨子生物发布公告称，公司与补足卖方及联席账簿管理人订立配售及认购协议，拟以每股66.65港元的价格配售3500万股现有股份，并通过补足认购同等数量新股份，预计募集资金总额约23.33亿港元，净额约22.94亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504213382733773.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02367","SG9999004311.SGD","LU2488822045.USD","BK1207"],"gpt_icon":0},{"id":"2528075772","title":"巨子生物旗下可复美检出违禁成分？陕西省药监局通报","url":"https://stock-news.laohu8.com/highlight/detail?id=2528075772","media":"南方都市报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528075772?lang=zh_cn&edition=full","pubTime":"2025-04-19 16:20","pubTimestamp":1745050800,"startTime":"0","endTime":"0","summary":"近日，巨子生物旗下护肤品牌可复美被消费者投诉含有违禁成分EGF一事引起热议。4月12日，可复美官方发布声明称，公司已委托两家专业检测机构分别采用两种检测方法对同批次产品独立检测，均未检出EGF。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250419162627973d6ae4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250419162627973d6ae4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","SG9999004311.SGD","BK1207","LU2488822045.USD"],"gpt_icon":0},{"id":"2528707106","title":"主品牌深陷EGF添加门 巨子生物业绩或将面临剧烈波动- DoNews","url":"https://stock-news.laohu8.com/highlight/detail?id=2528707106","media":"iDoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528707106?lang=zh_cn&edition=full","pubTime":"2025-04-18 10:02","pubTimestamp":1744941734,"startTime":"0","endTime":"0","summary":"然而，高增长表象下仍有隐忧，重营销轻研发、主品牌依赖与同质化竞争使得巨子生物高增长存疑。单一品牌依赖风险加剧，一旦可复美因市场竞争或质量问题受挫，公司整体业绩将面临剧烈波动。业内认为，若无法降低品牌依赖、提升研发投入突破技术瓶颈，巨子生物高增长神话或将面临终结。这场“EGF添加门”事件，不仅是对巨子生物产品质量的拷问，更是对其商业模式可持续性的深刻反思。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418100513973bfb06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418100513973bfb06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","SG9999004311.SGD","LU2488822045.USD","BK1207"],"gpt_icon":0},{"id":"2528871147","title":"每日卖空追踪 | 巨子生物 04月17日卖空量成交184.6万股，卖空比例为3.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528871147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528871147?lang=zh_cn&edition=full","pubTime":"2025-04-17 20:29","pubTimestamp":1744892987,"startTime":"0","endTime":"0","summary":"巨子生物北京时间04月17日，跌2.1%，卖空量成交184.6万股，较上一交易日增加272.18%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417202951a6bdf8a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417202951a6bdf8a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999004311.SGD","02367","BK1207","LU2488822045.USD"],"gpt_icon":0},{"id":"2528796428","title":"北水动向|北水成交净买入23.09亿 北水继续加仓科网股 全天抛售小米(01810)超13亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2528796428","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528796428?lang=zh_cn&edition=full","pubTime":"2025-04-17 17:50","pubTimestamp":1744883448,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月17日港股市场，北水成交净买入23.09亿港元，其中港股通(沪)成交净买入5.08亿港元，港股通(深)成交净买入18.01亿港元。北水净卖出最多的个股是盈富基金、小米集团-W、中海油。北水重新加仓芯片股。小米集团-W遭净卖出13.42亿港元。4月14日，小米集团核心子公司小米通讯200亿元公司债项目状态更新为“提交注册”。此外有媒体报道称，小米原定于4月底举行的2025年投资者日因故延期至6月3日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1280176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0228659784.USD","BK1502","LU1993786604.SGD","LU0211977185.USD","LU0348783233.USD","89988","LU1515016050.SGD","LU0642271901.SGD","LU0516422952.EUR","LU0140636845.USD","LU0348805143.USD","LU2087589342.USD","LU0229945570.USD","LU0611395673.USD","LU0054450605.USD","LU0264606111.USD","LU1188198961.HKD","LU0797268264.HKD","HBBD.SI","LU1880383440.USD","LU0593848301.USD","LU2097828805.USD","LU2097828474.EUR","LU2488822045.USD","02367","SG9999002950.SGD","LU0128522157.USD","LU2226246903.HKD","LU1023057109.AUD","IE00B543WZ88.USD","LU2097828631.EUR","01810","LU0499858438.USD","LU0737861699.HKD","LU0084288322.USD","LU0348784397.USD","LU1868837565.USD","BK1207","LU0132412106.USD","81810","HXXD.SI","LU1981816686.USD","XIACY","LU0572944931.SGD","LU0307460666.USD","LU0048580855.USD","LU0823413660.USD"],"gpt_icon":1},{"id":"2528164768","title":"花旗：维持巨子生物“买入”评级 目标价78.1港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528164768","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528164768?lang=zh_cn&edition=full","pubTime":"2025-04-17 15:33","pubTimestamp":1744875180,"startTime":"0","endTime":"0","summary":"巨子生物周四早上公布，配售最多3,500万股股份，相当于扩大后股本3.27%;配售价66.65港元，较上交易日收市价折让9.5%。花旗发布研报称，鉴于较大的折让，预期短期内该股的股价将会承压。尽管如此，巨子生物的盈利前景依然稳健，故维持该股的“买入”评级，目标价78.1港元。巨子生物表示，集资主要用于海外业务发展，因其现金大部分在中国境内。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417153718973aec18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417153718973aec18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367"],"gpt_icon":0},{"id":"2528757097","title":"花旗：维持巨子生物(02367)“买入”评级 目标价78.1港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528757097","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528757097?lang=zh_cn&edition=full","pubTime":"2025-04-17 15:16","pubTimestamp":1744874161,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，花旗发布研报称，鉴于较大的折让，预期短期内该股的股价将会承压。尽管如此，巨子生物(02367)的盈利前景依然稳健，故维持该股的“买入”评级，目标价78.1港元。巨子生物周四(17日)早上公布，配售最多3,500万股股份，相当于扩大后股本3.27%;配售价66.65港元，较上交易日(16日)收市价折让9.5%。集资总额23.33亿港元，所得净额22.94亿港元，配售及认购所得款项净额拟用于核心业务的发展及生态圈布局，包括品牌推广、市场营销、品类扩展、海外业务及研发投入;以及补充流动资金及作一般企业用途。巨子生物表示，集资主要用于海外业务发展，因其现金大部分在中国境内。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1280014.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02367"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xajuzi.com","stockEarnings":[{"period":"1week","weight":0.0075},{"period":"1month","weight":0.1317},{"period":"3month","weight":0.3931},{"period":"6month","weight":0.4403},{"period":"1year","weight":0.5859},{"period":"ytd","weight":0.6192}],"compareEarnings":[{"period":"1week","weight":0.0297},{"period":"1month","weight":-0.0082},{"period":"3month","weight":0.1003},{"period":"6month","weight":0.0816},{"period":"1year","weight":0.2198},{"period":"ytd","weight":0.1297}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"巨子生物控股有限公司是一家中国的投资控股公司。该公司通过其子公司主要从事基于生物活性材料的美容和健康产品的研发、生产和销售。该公司的主要产品包括功能性护肤品和医用敷料，其产品的关键生物活性成分为重组胶原蛋白。该公司还开发和生产基于人参皂苷技术的稀有功能食品。该公司主要在国内市场开展其业务。","exchange":"SEHK","name":"巨子生物","nameEN":"GIANT BIOGENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"巨子生物(02367)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供巨子生物(02367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"巨子生物,02367,巨子生物股票,巨子生物股票老虎,巨子生物股票老虎国际,巨子生物行情,巨子生物股票行情,巨子生物股价,巨子生物股市,巨子生物股票价格,巨子生物股票交易,巨子生物股票购买,巨子生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"巨子生物(02367)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供巨子生物(02367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}